First Time Loading...

Clinuvel Pharmaceuticals Ltd
ASX:CUV

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Watchlist
Price: 14.86 AUD -1.33% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one CUV stock under the Base Case scenario is 21.23 AUD. Compared to the current market price of 14.86 AUD, Clinuvel Pharmaceuticals Ltd is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CUV Relative Value
Base Case
21.23 AUD
Undervaluation 30%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.5
P/S
P/S
Price to Sales
8.5
vs History
93
vs Industry
52
Median 3Y
14.1
Median 5Y
28.3
Industry
8.1
Forward
8.2
More Details
24.7
P/E
P/E
Price to Earnings
24.7
vs History
90
vs Industry
7
Median 3Y
40.6
Median 5Y
55.7
Industry
26.2
Forward
21.5
More Details
17.6
P/OCF
P/OCF
Price to OCF
17.6
vs History
93
vs Industry
9
Median 3Y
24.4
Median 5Y
59
Industry
22.6
More Details
20.6
P/FCFE
P/FCFE
Price to FCFE
20.6
vs History
88
vs Industry
7
Median 3Y
25.2
Median 5Y
63.5
Industry
21.3
More Details
4.2
P/B
P/B
Price to Book Value
4.2
vs History
93
vs Industry
24
Median 3Y
7.4
Median 5Y
13.7
Industry
2.5
More Details
6.5
EV/S
EV/S
Enterprise Value to Sales
6.5
vs History
93
vs Industry
48
Median 3Y
12.2
Median 5Y
26.5
Industry
7.3
Forward
6.3
More Details
6
EV/GP
EV/GP
Enterprise Value to Gross Profit
6
vs History
69
vs Industry
53
Median 3Y
12.3
Median 5Y
11.6
Industry
9.1
More Details
11.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.2
vs History
93
vs Industry
9
Median 3Y
21.6
Median 5Y
47.4
Industry
4.4
Forward
12.7
More Details
11.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.2
vs History
93
vs Industry
9
Median 3Y
21.6
Median 5Y
47.4
Industry
4.3
Forward
13
More Details
13.5
EV/OCF
EV/OCF
Enterprise Value to OCF
13.5
vs History
93
vs Industry
10
Median 3Y
21.1
Median 5Y
55.2
Industry
5.4
More Details
15.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15.7
vs History
88
vs Industry
8
Median 3Y
21.3
Median 5Y
58.5
Industry
3.2
More Details
18.6
EV/IC
EV/IC
Enterprise Value to IC
18.6
vs History
93
vs Industry
15
Median 3Y
53
Median 5Y
81.3
Industry
5
More Details

Multiples Across Competitors

CUV Competitors Multiples
Clinuvel Pharmaceuticals Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Clinuvel Pharmaceuticals Ltd
ASX:CUV
744.9m AUD 8.5 24.7 11.2 11.2
US
Abbvie Inc
NYSE:ABBV
281.3B USD 5.2 58.4 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
148.1B USD 5.3 22 16.4 24.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.8B USD 10.5 28.7 23 24
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
101.7B USD 7.8 25.7 17.2 18.9
AU
CSL Ltd
ASX:CSL
133B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
81.1B USD 3 167.6 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
45.8B USD 6.7 -9.7 -10.4 -8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 26.8 13.8 17.2
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
CUV intrinsic value, competitors valuation, and company profile.
DCF Valuation
CUV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CUV stock valuation using valuation multiples.
Wall Street Estimates
CUV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CUV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.